Seres Therapeutics Inc.
MCRB | NASDAQ
$3.98
-$0.09 (-2.21%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.88M | 1.15M | 789K | 351K | n/a | n/a | n/a | 64K | 64K | 126.54M | 126.02M | 126.93M | 130.37M | 5.11M | 7.13M | 13.37M | 136.66M | 140.7M | 144.93M | 155.27M | 29.96M | 30.74M |
Cost of Revenue | 328K | 1.39M | 4.13M | 23.07M | 11.12M | 10.06M | 26.03M | 20.9M | 24.24M | 71.03M | 95.51M | 141.73M | 180.1M | 177.24M | 172.92M | 163.45M | 160.22M | 152.24M | 141.89M | 130.01M | 90.12M | 54.17M |
Gross Profit | 1.56M | -240K | -3.34M | -22.72M | -11.12M | -10.06M | -26.03M | -20.83M | -24.17M | 55.51M | 30.51M | -14.8M | -49.73M | -172.13M | -165.79M | -150.08M | -23.56M | -11.54M | 3.04M | 25.26M | -60.16M | -23.43M |
Operating Income | -84.03M | -87.64M | -93.97M | -103.43M | -110.12M | -114.11M | -121.31M | -132.01M | -147.42M | -69.03M | -105.16M | -133.94M | -148.46M | -261.31M | -246.49M | -227.62M | -100.1M | -84.92M | -64.49M | -32.96M | -131.36M | -103.76M |
Interest Income | 1.57M | 1.93M | 2.23M | 2.22M | 2.25M | 2.94M | 3.97M | 5.5M | 7.42M | 7.92M | 7.3M | 6.74M | 5.04M | 3.71M | 3.06M | 2.13M | 1.85M | 2.29M | 2.87M | 3M | 2.51M | 1.75M |
Pretax Income | -22.46M | -46.9M | 5.7M | 5.39M | -53.85M | -60.19M | -125.77M | -151.38M | -141.36M | -68.61M | -106.89M | -134.43M | -153.42M | -264.71M | -250.16M | -231.36M | -103.14M | -86.74M | -65.58M | -33.83M | -132.33M | -104.71M |
Net Income | -22.46M | -46.9M | 5.7M | 5.39M | 85.97M | 72.95M | 136K | -25.48M | -162.11M | -82.68M | -113.72M | -141.27M | -153.42M | -264.71M | -250.16M | -231.36M | -103.14M | -86.74M | -65.58M | -33.83M | -132.33M | -104.71M |
Selling & General & Admin | 32.15M | 35.34M | 39.16M | 44.08M | 45.91M | 48.72M | 51.78M | 56.55M | 64.68M | 79.66M | 87.19M | 92.36M | 91.31M | 83.59M | 79.69M | 77.8M | 78.98M | 76.09M | 69.26M | 59.35M | 47.34M | 36.38M |
Research & Development | 46.64M | 50.43M | 49.06M | 50.22M | 54.06M | 56.93M | 64.6M | 78.61M | 87.3M | 118.29M | 142.76M | 162.14M | 180.1M | 177.24M | 172.92M | 163.45M | 160.22M | 152.24M | 141.89M | 130.01M | 113.99M | 98.13M |
Other Expenses | 6.81M | 1.63M | 2.41M | -13.58M | -966K | -1.6M | -21.09M | -23.98M | -28.73M | -73.41M | -94.28M | -135.35M | -172.68M | -171.65M | -171.92M | -163.71M | -162.66M | -154.95M | -143.62M | -131.13M | -90.12M | -54.17M |
Operating Expenses | 85.59M | 87.4M | 90.63M | 80.71M | 99M | 104.05M | 95.29M | 111.17M | 123.25M | 124.53M | 135.67M | 119.14M | 98.73M | 89.18M | 80.7M | 77.54M | 76.54M | 73.38M | 67.53M | 58.22M | 71.2M | 80.34M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 3.45M | 8.11M | 12.14M | 16.15M | 15.89M | 13.18M | 11.03M | 8.74M | 7.06M | 6.02M | 4.88M | 3.9M | 3.13M | 2.91M | 2.93M | 2.92M | 2.9M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 85.92M | 88.79M | 94.76M | 103.78M | 110.12M | 114.11M | 121.31M | 132.07M | 147.49M | 195.56M | 231.17M | 260.86M | 278.83M | 266.42M | 253.62M | 240.99M | 236.76M | 225.62M | 209.42M | 188.23M | 161.32M | 134.51M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 9.64M | 9.58M | 8.86M | 8.76M | 8.74M | 8.7M | 8.65M | 7.63M | 7.58M | 7.31M | 6.46M | 6.41M | 6.39M | 6.29M | 6.26M | 6.13M | 4.61M | 4.61M | 4.59M | 4.59M | 4.58M | 4.58M |
Shares Outstanding (Diluted) | 9.64M | 9.58M | 8.87M | 8.77M | 8.74M | 8.71M | 8.65M | 7.63M | 7.58M | 7.31M | 6.46M | 6.41M | 6.49M | 6.29M | 6.26M | 6.13M | 4.61M | 4.61M | 4.59M | 4.75M | 4.58M | 4.58M |
EPS (Basic) | -2.42 | -5.18 | 0.66 | 0.62 | -7.91 | -9.98 | -19.23 | -23.80 | -23.67 | -12.04 | -17.86 | -22.47 | -24.80 | -46.13 | -47.10 | -47 | -22.33 | -18.85 | -14.31 | -7.42 | -29.54 | -24.64 |
EPS (Diluted) | -2.41 | -5.17 | 0.66 | 0.61 | -7.92 | -9.99 | -19.23 | -23.80 | -23.67 | -12.16 | -17.98 | -22.59 | -24.92 | -46.13 | -47.10 | -47 | -22.84 | -19.35 | -14.81 | -7.92 | -29.54 | -24.64 |
EBITDA | -44.34M | -41.87M | 11.03M | 9.67M | -49.22M | -55.2M | -119.69M | -140.72M | -130.42M | -54.38M | -91.48M | -121.18M | -138.38M | -251.19M | -237.51M | -219.93M | -92.95M | -77.57M | -57.28M | -25.96M | -124.39M | -96.52M |
EBIT | -48.32M | -46.9M | 5.7M | 5.39M | -53.85M | -60.19M | -125.15M | -146.74M | -136.72M | -60.78M | -97.72M | -127.42M | -144.68M | -257.65M | -244.14M | -226.48M | -99.25M | -83.61M | -63.23M | -31.86M | -130.37M | -102.77M |
Depreciation & Amortization | 3.98M | 5.03M | 5.33M | 4.28M | 4.62M | 4.99M | 5.47M | 6.02M | 6.3M | 6.4M | 6.24M | 6.24M | 6.3M | 6.46M | 6.63M | 6.55M | 6.3M | 6.04M | 5.95M | 5.9M | 5.99M | 6.25M |
Add to Watchlist
Select watchlists to add or remove MCRB